The National Institutes of Health (NIH) will resume important meetings and travel associated with the critical grant-review ...
A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.
The interim leader of the National Institutes of Health gave some clarification tied to Trump administrations restrictions on ...
Arizona universities, researchers wait to learn their funding future during NIH communication freeze
A Trump administration order to freeze communication at the National Institutes of Health has disrupted scientific research ...
National Institutes of Health (NIH) Acting Director Matthew Memoli sought to clarify the extent of the Trump administration's freeze on communications and other functions within the Health and ...
Acting NIH director Memoli clarifies communication restrictions as White House moves to freeze US government grants ...
Just days after President Trump imposed broad restrictions on communications, meetings, travel and public appearances at the ...
U.S. Rep. Don Beyer of Virginia led 89 of his colleagues in decrying attacks on the NIH that endanger vitally important medical research.
HHS announced plans to reevaluate agency practices to ensure they meet requirements under the Hyde Amendment, which prohibits ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
In this week’s edition of InnovationRx, we look at HHS nominee Robert F. Kennedy Jr.’s first Senate confirmation hearing, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback